Viewing Study NCT07143318


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:07 AM
Study NCT ID: NCT07143318
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2025-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First-in-Human Single and Multiple Dose of KLA578-1 for Injection
Sponsor: Sichuan Kelun Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module